J. Cohen, The detection and interpretation of endotoxaemia, Intens Care Med, vol.26, pp.51-056, 2000.

J. De-barros, T. Gautier, and W. Sali, Quantitative lipopolysaccharide analysis using HPLC/MS/MS and its combination with the limulus amebocyte lysate assay, J Lipid Res, vol.56, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01687093

M. Wendel, R. Paul, and A. R. Heller, Lipoproteins in inflammation and sepsis. II. Clinical aspects, Intens Care Med, vol.33, pp.25-35, 2007.

T. Gautier and L. Lagrost, Plasma PLTP (phospholipid-transfer protein): an emerging role in "reverse lipopolysaccharide transport" and innate immunity. -PubMed -NCBI, Biochem Soc T, vol.39, pp.984-988, 2011.

C. Erridge, Diet, commensals and the intestine as sources of pathogen-associated References, 2011.

D. Weil, P. De-barros, J. Mourey, and G. , Circulating levels of 3-hydroxymyristate, a direct quantification of endotoxaemia in noninfected cirrhotic patients, Liver Int, vol.67, p.1031, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01862374

J. Pais-de-barros, T. Gautier, and W. Sali, Quantitative lipopolysaccharide analysis using HPLC/MS/MS and its combination with the limulus amebocyte lysate assay, J Lipid Res, vol.56, pp.1363-1369, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01687093

J. L. Vincent, R. Moreno, and J. Takala, The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure, Intensive Care Med, vol.22, pp.707-710, 1996.

M. M. Levy, M. P. Fink, and J. C. Marshall, SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference, pp.1250-1256, 2001.

R. S. Munford, Endotoxemia-menace, marker, or mistake, J Leukocyte Biol, vol.100, issue.4, pp.687-698, 2016.

E. Charbonney, Endotoxemia Following Multiple Trauma, Crit Care Med, vol.44, issue.2, pp.335-341, 2016.

N. E. Boutagy, R. P. Mcmillan, M. I. Frisard, and M. W. Hulver, Metabolic endotoxemia with obesity: Is it real and is it relevant?, Biochimie, vol.124, pp.11-20, 2016.

A. Besredka, De l'anti-endotoxine typhique et des anti-endotoxines, en général, Annales de l'Institut Pasteur, vol.20, pp.149-154, 1906.

N. Bhat, M. Bieber, C. Chapman, F. Stevenson, and N. Teng, Human antilipid A monoclonal antibodies bind to human B cells and the i antigen on cord red blood cells, J Immunol Baltim Md, vol.151, issue.9, pp.5011-5032, 19501993.

K. Hanasawa, Novel mechanical assistance in the treatment of endotoxic and septicemic shock, ASAIO transactions, vol.35, issue.3, pp.341-343, 1989.

P. R. Dellinger, Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial, Jama, vol.320, issue.14, pp.1455-1463, 2018.

S. Harm, Endotoxin adsorbents in extracorporeal blood purification: do they fulfill expectations?, Int J Artif Organs, vol.37, issue.3, p.232, 2014.

R. Roth, F. Levin, and J. Levin, Distribution of bacterial endotoxin in human and rabbit blood and effects of stroma-free hemoglobin, Infect Immun, vol.61, issue.8, pp.3209-3224, 1993.

J. H. Levels, P. R. Abraham, E. P. Van-barreveld, J. C. Meijers, and S. J. Van-deventer,

, Distribution and Kinetics of Lipoprotein-Bound Lipoteichoic Acid, Infect Immun, vol.71, issue.6, pp.3280-3284, 2003.

V. Deckert, Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis, Sci Rep-uk, vol.7, issue.1, p.3053, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01542885

J. Levels, Lipopolysaccharide Is Transferred from High-Density to Low-Density Lipoproteins by Lipopolysaccharide-Binding Protein and Phospholipid Transfer Protein, Infect Immun, vol.73, issue.4, pp.2321-2326, 2005.

R. J. Tripp, A. Tabares, H. Wang, and S. Lanza-jacoby,

, Apolipoproteins B and E in the Fasted Septic Rat: Factors in the Development of Hypertriglyceridemia, J Surg Res, vol.55, issue.5, pp.465-472, 1993.

M. Cirstea, Decreased high-density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsis

, Intensive Care Med, vol.38, pp.289-294, 2007.

L. Lagrost, Low Preoperative Cholesterol Level Is a Risk Factor of Sepsis and Poor Clinical Outcome in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass*, Crit Care Med, vol.42, issue.5, pp.1065-1073, 2014.

L. Lagrost, C. Girard, D. Masson, and C. Bonithon-kopp, The authors reply, Crit Care Med, vol.42, issue.10, pp.686-687, 2014.

K. R. Walley, PCSK9 is a critical regulator of the innate immune response and septic shock outcome, Sci Transl Med, vol.6, issue.258, pp.258-143, 2014.

T. Gautier and L. Lagrost, Plasma PLTP (phospholipid-transfer protein): an emerging role in 'reverse lipopolysaccharide transport' and innate immunity, Biochem Soc T, vol.39, issue.4, pp.984-988, 2011.

T. Gautier, Effect of Plasma Phospholipid Transfer Protein Deficiency on Lethal Endotoxemia in Mice, J Biol Chem, vol.283, issue.27, pp.18702-18710, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00284576

K. Genga, Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivors, Natl Vital Stat Rep, vol.38, p.5, 2018.

, Polymyxin Studied by NMR Spectroscopy, J Biol Chem, vol.284, issue.17, pp.11498-11506, 2009.

T. Asahi, T. Yamamoto, and H. Kutsuki, Blood Purification Therapies Using Dextran Sulfate Cellulose Columns Liposorber and Selesorb, Ther Apher Dial, vol.7, issue.1, pp.73-77, 2003.

T. Agishi, Double filtration plasmapheresis, Transactions -Am Soc Artif Intern Organs, vol.26, pp.406-417, 1980.

M. M. Levy, SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference, 2001.

, Crit Care Med, vol.31, issue.4, pp.1250-1256, 2003.

D. M. Payen, Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial, Intens Care Med, vol.41, issue.6, pp.975-984, 2015.

C. J. Wiedermann, Association of endotoxemia with carotid atherosclerosis and cardiovascular disease Prospective results from the bruneck study, J Am Coll Cardiol, vol.34, issue.7, pp.1975-1981, 1999.

R. Tatamia, Regression of coronary atherosclerosis by combined LDLapheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study, Atherosclerosis, vol.95, issue.1, pp.1-13, 1992.

R. C. Bone, R. A. Balk, F. B. Cerra, P. R. Dellinger, A. M. Fein et al., Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis, Chest, vol.101, issue.6, pp.1644-55, 1992.

M. M. Levy, M. P. Fink, J. C. Marshall, A. E. Angus, D. Cook et al., , 2001.

, SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference, vol.31, pp.1250-1256, 2003.

M. Singer, C. S. Deutschman, C. Seymour, M. Shankar-hari, D. Annane et al.,

, Sepsis-3), The Third International Consensus Definitions for Sepsis and Septic Shock, vol.315, p.801, 2016.

J. Vincent, R. Moreno, J. Takala, S. Willatts, . Da et al., The SOFA (Sepsisrelated Organ Failure Assessment) score to describe organ dysfunction/failure, Intensive Care Medicine, vol.22, issue.7, p.710, 1996.

J. Quenot, C. Binquet, F. Kara, O. Martinet, F. Ganster et al., The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study, Crit Care, vol.17, issue.2, p.65, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00873494

C. Brun-buisson, P. Meshaka, P. Pinton, B. Vallet, and E. Group, EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units, Intens Care Med, vol.30, issue.4, pp.580-588, 2004.

G. S. Martin, D. M. Mannino, S. Eaton, and M. Moss, The Epidemiology of Sepsis in the United States from 1979 through 2000, New Engl J Medicine, vol.348, issue.16, pp.1546-54, 2003.

T. Lagu, M. B. Rothberg, M. Shieh, P. S. Pekow, J. S. Steingrub et al.,

, Hospitalizations, costs, and outcomes of severe sepsis in the United States, Crit Care Med, vol.40, issue.3, pp.754-61, 2003.

H. Ait-oufella, S. Lemoinne, P. Boelle, A. Galbois, J. Baudel et al., Mottling score predicts survival in septic shock, Intens Care Med, vol.37, issue.5, p.807, 2011.

B. Levy, S. Gibot, P. Franck, A. Cravoisy, and P. Bollaert, Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study, Lancet, vol.365, issue.9462, p.875, 2005.

A. Dargent, M. Nguyen, I. Fournel, A. Bourredjem, P. Charles et al.,

, Vasopressor Cumulative Dose Requirement and Risk of Early Death During Septic Shock: An Analysis from the Episs Cohort, Shock, vol.49, issue.6, p.1, 2017.

A. Kumar, D. Roberts, K. E. Wood, B. Light, J. E. Parrillo et al., Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock&ast, Crit Care Med, vol.34, issue.6, pp.1589-96, 2006.

D. Annane, A. Renault, C. Brun-buisson, B. Megarbane, J. Quenot et al., Hydrocortisone plus Fludrocortisone for Adults with Septic Shock, New Engl J Medicine, vol.378, issue.9, p.818, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01743764

M. M. Levy, L. E. Evans, and A. Rhodes, The Surviving Sepsis Campaign Bundle, 2018.

, Update. Crit Care Med, vol.46, issue.6, p.1000, 2018.

D. C. Angus, The Search for Effective Therapy for Sepsis: Back to the Drawing Board?, Jama, vol.306, issue.23, pp.2614-2619, 2011.

G. Bernard, J. Vincent, P. Laterre, S. Larosa, J. Dhainaut et al., Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis, New Engl J Medicine, vol.344, issue.10, pp.699-709, 2001.

A. F. Suffredini, A Role for Hydrocortisone Therapy in Septic Shock?, New Engl J Medicine, vol.378, issue.9, pp.860-861, 2018.

P. M. Klouwenberg, O. L. Cremer, L. A. Van-vught, D. S. Ong, J. F. Frencken et al., Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study, Crit Care, vol.19, issue.1, p.319, 2015.

. Harbarth-s, . Holeckova-k, . Froidevaux-c, . Pittet-d, . Ricou-r et al.,

. Ge, Diagnostic Value of Procalcitonin, Interleukin-6, and Interleukin-8 in Critically Ill Patients Admitted with Suspected Sepsis, Am J Resp Crit Care, vol.164, issue.3, pp.396-402, 2001.

K. L. Becker, R. Snider, and E. S. Nylen, Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations, Crit Care Med, vol.36, issue.3, pp.941-52, 2008.

B. M. Tang, G. D. Eslick, J. C. Craig, and A. S. Mclean, Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis, Lancet Infect Dis, vol.7, issue.3, pp.210-217, 2007.

Y. Wu, F. Wang, X. Fan, R. Bao, L. Bo et al., Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and metaanalysis, Crit Care, vol.16, issue.6, p.229, 2012.

C. Pierrakos and J. Vincent, Sepsis biomarkers: a review, Crit Care, vol.14, issue.1, p.15, 2010.

M. Singer, Biomarkers in sepsis, Curr Opin Pulm Med, vol.19, issue.3, pp.305-314, 2013.

T. Van-engelen, W. Wiersinga, B. P. Scicluna, and T. Van-der-poll, Biomarkers in Sepsis. Crit Care Clin, vol.34, issue.1, pp.139-52, 2018.

L. Mchugh, T. A. Seldon, R. A. Brandon, J. T. Kirk, A. Rapisarda et al., A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts, Plos Med, vol.12, issue.12, p.1001916, 2015.

D. Cameron, M. J. Piccart-gebhart, R. D. Gelber, M. Procter, A. Goldhirsch et al.,

E. Azambuja, 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial, Lancet, vol.389, pp.1195-205, 2017.

M. Singer, Personalizing Sepsis Care, Crit Care Clin, vol.34, issue.1, pp.153-60, 2018.

R. Pfeiffer, . Untersuchungen, and C. Das, Zeitschrift Für Hyg Und Infektionskrankheiten, vol.1892, issue.1, pp.393-412

N. Gamaleia, Sur la destruction des microbes dans les organismes fébricitants, Annales de l'Institut Pasteur, vol.2, pp.229-274, 1888.

A. Besredka, De l'anti-endotoxine typhique et des anti-endotoxines, en général, Annales de l'Institut Pasteur, vol.20, pp.149-54, 1906.

A. Boivin and L. Mesrobeanu, Contribution à l'étude de la composition chimique des bactéries, Comptes Rendus de la Société de Biologie, issue.112, pp.76-85, 1933.

J. L. Hartwell, M. J. Shear, J. R. Adams, and A. Perrault, Chemical Treatment of Tumors. VII. Nature of the Hemorrhage-Producing Fraction From Serratia marcescens (Bacillus prodigiosus) Culture Filtrate, Jnci J National Cancer Inst, 1943.

D. C. Angus and T. Van-der-poll, Severe sepsis and septic shock, New Engl J Medicine, vol.369, issue.9, p.851, 2013.

S. E. Greisman and R. B. Hornick, Comparative Pyrogenic Reactivity of Rabbit and Man to Bacterial Endotoxin *, P Soc Exp Biol Med, vol.131, issue.4, pp.1154-1162, 1969.

T. A. Da-silva, H. Kaulbach, F. Chuidian, D. Lambert, A. Suffredini et al., Clinical implications of antibiotic-induced endotoxin release in septic shock, Intens Care Med, vol.28, issue.7, p.833, 2002.

T. Gautier and L. Lagrost, Plasma PLTP (phospholipid-transfer protein): an emerging role in "reverse lipopolysaccharide transport" and innate immunity

, Biochem Soc T, vol.39, issue.4, pp.984-988, 2011.

J. C. Hurley, P. Nowak, L. Öhrmalm, C. Gogos, A. Armaganidis et al., Endotoxemia as a diagnostic tool for patients with suspected bacteremia caused by gram-negative organisms: a meta-analysis of 4 decades of studies, J Clin Microbiol, vol.53, issue.4, pp.1183-1191, 2015.

S. Van-deventer, H. Büller, J. Ten-cate, A. Sturk, and W. Pauw, Endotoxaemia: an early predictor of septicaemia in febrile patients, Lancet, vol.1, issue.8586, pp.605-609, 1988.

M. Yoshida, T. Obayashi, H. Tamura, S. Tanaka, T. Kawai et al.,

, Diagnostic and prognostic significance of plasma endotoxin determination in febrile patients with haematological malignancies, Eur J Cancer, vol.30, issue.2, pp.145-152, 1994.

P. Langevelde, K. Joop, J. Van-loon, M. Frölich, P. Groeneveld et al., Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality, Clin Infect Dis, vol.31, issue.6, pp.1343-1348, 2000.

J. Levin, T. Poore, N. Young, S. Margolis, N. Zauber et al., Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement, Ann Intern Med

J. C. Marshall, D. Foster, J. Vincent, D. J. Cook, J. Cohen et al.,

, Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study, J Infect Dis, vol.190, issue.3, pp.527-534, 2004.

J. Hurley, Does gram-negative bacteraemia occur without endotoxaemia? A metaanalysis using hierarchical summary ROC curves, Eur J Clin Microbiol, vol.29, issue.2, pp.207-222, 2010.

C. Erridge, Diet, commensals and the intestine as sources of pathogen-associated molecular patterns in atherosclerosis, type 2 diabetes and non-alcoholic fatty liver disease, Atherosclerosis, vol.216, issue.1, pp.1-6, 2011.

I. Spadoni, E. Zagato, A. Bertocchi, R. Paolinelli, E. Hot et al., A gutvascular barrier controls the systemic dissemination of bacteria, Science, vol.350, issue.6262, pp.830-834, 2015.

C. Venet, F. Zeni, A. Viallon, A. Ross, P. Pain et al., Endotoxaemia in patients with severe sepsis or septic shock, Intens Care Med, vol.26, issue.5, pp.538-582, 2000.

D. Bates, J. Parsonnet, P. Ketchum, E. Miller, T. Novitsky et al., Limulus amebocyte lysate assay for detection of endotoxin in patients with sepsis syndrome

, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol.27, p.591, 1998.

F. Strutz, G. Heller, K. Krasemann, B. Krone, and G. Müller, Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome, Intens Care Med, vol.25, issue.5, pp.435-479, 1999.

A. Goldie, K. Fearon, J. Ross, G. Barclay, R. Jackson et al., Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group, JAMA: the journal of the American Medical Association, vol.274, issue.2, pp.172-177, 1995.

S. Opal, P. Scannon, J. Vincent, M. White, S. Carroll et al., Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock, J Infect Dis, vol.180, issue.5, pp.1584-1589, 1999.

J. C. Hurley, B. Guidet, G. Offenstadt, and M. E. , Endotoxemia and mortality prediction in ICU and other settings: underlying risk and co-detection of gram negative bacteremia are confounders, Crit Care, vol.16, issue.4, p.148, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00731506

R. Elin, R. Robinson, A. Levine, and S. Wolff, Lack of clinical usefulness of the limulus test in the diagnosis of endotoxemia, New Engl J Medicine, vol.293, issue.11, pp.521-524, 1975.

J. Wong, Y. Zhang, A. Patidar, E. Vilar, M. Finkelman et al., Is Endotoxemia in Stable Hemodialysis Patients an Artefact? Limitations of the Limulus Amebocyte Lysate Assay and Role of (1?3)-?-D Glucan, Plos One, vol.11, issue.10, p.164978, 2016.

P. R. Dellinger, S. M. Bagshaw, M. Antonelli, D. M. Foster, D. J. Klein et al., Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial, Jama, vol.320, issue.14, pp.1455-1463, 2018.

D. M. Payen, J. Guilhot, Y. Launey, A. Lukaszewicz, M. Kaaki et al., Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial, Intens Care Med, vol.41, issue.6, pp.975-984, 2015.

R. S. Munford, Endotoxemia-menace, marker, or mistake?, J Leukocyte Biol, vol.100, issue.4, pp.687-698, 2016.

C. R. Raetz, C. Whitfield, and . Lipopolysaccharide-endotoxins, Biochemistryus, vol.71, issue.1, pp.635-700, 2002.

K. Brandenburg, S. S. Funari, M. Koch, and U. Seydel, Investigation into the Acyl Chain Packing of Endotoxins and Phospholipids under Near Physiological Conditions by WAXS and FTIR Spectroscopy, J Struct Biol, vol.128, issue.2, pp.175-86, 1999.

S. Akira and K. Takeda, Toll-like receptor signalling, Nat Rev Immunol, vol.4, issue.7, pp.499-511, 2004.

T. Fujita, M. Matsushita, and Y. Endo, The lectin-complement pathway -its role in innate immunity and evolution, Immunol Rev, vol.198, issue.1, pp.185-202, 2004.

W. Howell, Observations upon the chemical composition and coagulation of the blood of Limulus polyphemus. Callinectes hastatus, and Cucumaria sp

, Johns Hopkins University Circular, vol.43, pp.4-5, 1885.

F. B. Levin-j, . The, . Of, . In, . Extracellular et al., Johns Hopkins Hosp, vol.115, pp.265-74, 1964.

A. Gnauck, R. G. Lentle, and M. C. Kruger, The Limulus Amebocyte Lysate assay may be unsuitable for detecting endotoxin in blood of healthy female subjects, J Immunol Methods, vol.416, pp.146-56, 2015.

R. Roth, F. Levin, and J. Levin, Optimization of detection of bacterial endotoxin in plasma with the Limulus test, J Laboratory Clin Medicine, vol.116, issue.2, pp.153-61, 1990.

K. Brandenburg, J. Howe, T. Gutsman, and P. Garidel, The Expression of Endotoxic Activity in the Limulus Test as Compared to Cytokine Production in Immune Cells, Curr Med Chem, vol.16, issue.21, pp.2653-60, 2009.

A. D. Romaschin, D. M. Harris, M. B. Ribeiro, J. Paice, D. M. Foster et al., A rapid assay of endotoxin in whole blood using autologous neutrophil dependent chemiluminescence, J Immunol Methods, vol.212, issue.2, pp.169-85, 1998.

A. D. Romaschin, D. J. Klein, and J. C. Marshall, Bench-to-bedside review: Clinical experience with the endotoxin activity assay, Crit Care, vol.16, issue.6, p.248, 2012.

N. Bhat, M. Bieber, C. Chapman, F. Stevenson, and N. Teng, Human antilipid A monoclonal antibodies bind to human B cells and the i antigen on cord red blood cells, J Immunol Baltim Md, vol.151, issue.9, pp.5011-5032, 1950.

A. Kuksis, Lipid chromatographic analysis

. Dekker, IX + 289 pp., SFr. 115.00, ISBN 0-8247-6357-2, J Chromatogr B Biomed Sci Appl, vol.146, issue.1, p.181, 1976.

S. K. Maitra, M. C. Schotz, T. T. Yoshikawa, and L. B. Guze, Determination of lipid A and endotoxin in serum by mass spectroscopy, Proc National Acad Sci, vol.75, issue.8, pp.3993-4000, 1978.

S. Maitra, R. Nachum, and F. Pearson, Establishment of beta-hydroxy fatty acids as chemical marker molecules for bacterial endotoxin by gas chromatography-mass spectrometry, Applied and environmental microbiology, vol.52, issue.3, pp.510-514, 1986.

B. Szponar, L. Kra?nik, T. Hryniewiecki, A. Gamian, and L. Larsson, Distribution of 3-hydroxy fatty acids in tissues after intraperitoneal injection of endotoxin, Clin Chem, vol.49, issue.7, pp.1149-1153, 2003.

J. De-barros, T. Gautier, W. Sali, C. Adrie, H. Choubley et al.,

, Quantitative lipopolysaccharide analysis using HPLC/MS/MS and its combination with the limulus amebocyte lysate assay, J Lipid Res, vol.56, issue.7, pp.1363-1369, 2015.

J. I. Gallin, D. Kaye, O. 'leary, and W. M. , Serum Lipids in Infection, New Engl J Medicine, vol.281, issue.20, pp.1081-1087, 1969.

J. Samra, L. Summers, and K. Frayn, Sepsis and fat metabolism, Brit J Surg, vol.83, issue.9, pp.1186-96, 1996.

R. J. Tripp, A. Tabares, H. Wang, and S. Lanza-jacoby,

, Apolipoproteins B and E in the Fasted Septic Rat: Factors in the Development of Hypertriglyceridemia, J Surg Res, vol.55, issue.5, pp.465-72, 1993.

A. M. Barcia and H. W. Harris, Triglyceride-Rich Lipoproteins as Agents of Innate Immunity, Clin Infect Dis, vol.41, issue.Supplement_7, pp.498-503, 2005.

R. Roth, F. Levin, and J. Levin, Distribution of bacterial endotoxin in human and rabbit blood and effects of stroma-free hemoglobin, Infect Immun, vol.61, issue.8, pp.3209-3224, 1993.

R. Ulevitch, A. Johnston, and D. Weinstein, New function for high density lipoproteins

, Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma, J Clin Invest, vol.67, issue.3, pp.827-864, 1981.

V. B. Lenten, A. Fogelman, M. Haberland, and P. Edwards, The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide, Proc National Acad Sci, vol.83, issue.8, pp.2704-2712, 1986.

R. Ulevitch and A. Johnston, The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum, J Clin Invest, vol.62, issue.6, pp.1313-1337, 1978.

R. L. Kitchens, G. Wolfbauer, J. J. Albers, and R. S. Munford, Plasma Lipoproteins Promote the Release of Bacterial Lipopolysaccharide from the Monocyte Cell Surface, J Biol Chem, vol.274, issue.48, pp.34116-34138, 1999.

E. B. Eichbaum, H. W. Harris, J. P. Kane, and J. H. Rapp, Chylomicrons can inhibit endotoxin activity in vitro, J Surg Res, vol.51, issue.5, pp.413-419, 1991.

H. Harris, E. Eichbaum, J. Kane, and J. Rapp, Detection of endotoxin in triglyceride-rich lipoproteins in vitro, J Laboratory Clin Medicine, vol.118, issue.2, pp.186-93, 1991.

H. Harris, C. Grunfeld, K. Feingold, and J. Rapp, Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice, J Clin Invest, vol.86, issue.3, pp.696-702, 1990.

T. Parker, D. Levine, J. Chang, J. Laxer, C. Coffin et al., Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood, Infect Immun, vol.63, issue.1, pp.253-261, 1995.

R. Medzhitov, Toll-like receptors and innate immunity, Nat Rev Immunol, vol.1, issue.2, p.35100529, 2001.

B. Yu and S. D. Wright, Catalytic Properties of Lipopolysaccharide (LPS) Binding Protein TRANSFER OF LPS TO SOLUBLE CD14, J Biol Chem, vol.271, issue.8, pp.4100-4105, 1996.

C. D. Bingle and C. J. Craven, Meet the relatives: a family of BPI-and LBP-related proteins, Trends Immunol, vol.25, issue.2, pp.53-58, 2004.

L. Lagrost, C. Desrumaux, D. Masson, V. Deckert, and P. Gambert, Structure and function of the plasma phospholipid transfer protein, Curr Opin Lipidol, vol.9, issue.3, pp.203-212, 1998.

M. C. Cheung, T. Vaisar, X. Han, J. W. Heinecke, and J. J. Albers, Phospholipid transfer protein in human plasma associates with proteins linked to immunity and inflammation, Biochemistry-us, vol.49, issue.34, pp.7314-7336, 2010.

J. Levels, J. Marquart, P. Abraham, A. Van-den-ende, H. Molhuizen et al., Lipopolysaccharide Is Transferred from High-Density to Low-Density Lipoproteins by Lipopolysaccharide-Binding Protein and Phospholipid Transfer Protein, Infect Immun, vol.73, issue.4, pp.2321-2326, 2005.

E. Hailman, J. Albers, G. Wolfbauer, A. Tu, and S. Wright, Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein, J Biol Chem, vol.271, issue.21, p.12172, 1996.

T. Gautier, A. Klein, V. Deckert, C. Desrumaux, N. Ogier et al., Effect of Plasma Phospholipid Transfer Protein Deficiency on Lethal Endotoxemia in Mice, J Biol Chem, vol.283, issue.27, pp.18702-18712, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00284576

Y. Yu, Y. Cui, Y. Zhao, S. Liu, G. Song et al., The binding capability of plasma phospholipid transfer protein, but not HDL pool size, is critical to repress LPS induced inflammation, Sci Rep-uk, vol.6, issue.1, p.20845, 2016.

V. Deckert, S. Lemaire, P. Ripoll, J. De-barros, J. Labbé et al.,

, Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis. Sci Rep-uk, vol.7, p.3053, 2017.

K. R. Walley, Role of lipoproteins and proprotein convertase subtilisin/kexin type 9 in endotoxin clearance in sepsis, Curr Opin Crit Care, vol.22, issue.5, p.469, 2016.

J. H. Boyd, C. D. Fjell, J. A. Russell, D. Sirounis, M. S. Cirstea et al., Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during Sepsis, J Innate Immun, vol.8, issue.2, pp.211-231, 2016.

D. Cunningham, D. E. Danley, K. F. Geoghegan, M. C. Griffor, J. L. Hawkins et al., Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia, Nat Struct Mol Biol, vol.14, issue.5, pp.413-422, 2007.

K. R. Walley, K. R. Thain, J. A. Russell, M. P. Reilly, N. J. Meyer et al., PCSK9 is a critical regulator of the innate immune response and septic shock outcome, Sci Transl Med, vol.6, issue.258, pp.258-143, 2014.

J. Berger, A. Valdes, J. Gromada, N. Anderson, and J. D. Horton, Inhibition of PCSK9 does not improve lipopolysaccharide-induced mortality in mice, J Lipid Res, vol.58, issue.8, pp.1661-1669, 2017.

K. Tateda, T. Matsumoto, S. Miyazaki, and K. Yamaguchi, Lipopolysaccharide-induced lethality and cytokine production in aged mice, Infect Immun, vol.64, issue.3, pp.769-74, 1996.

C. J. Thomas, B. P. Gangadhar, N. Surolia, and A. Surolia, Kinetics and Mechanism of the Recognition of Endotoxin by Polymyxin B, J Am Chem Soc, vol.120, issue.48, pp.12428-12462, 1998.

A. C. Issekutz, Removal of gram-negative endotoxin from solutions by affinity chromatography, J Immunol Methods, vol.61, issue.3, pp.275-81, 1983.

J. Cohen, M. Aslam, C. Pusey, and C. Ryan, Protection from Endotoxemia: A Rat Model of Plasmapheresis and Specific Adsorption with Polymyxin B, J Infect Dis, vol.155, issue.4, pp.690-695, 1987.

S. Harm, S. Harm, D. Falkenhagen, D. Falkenhagen, J. Hartmann et al.,

, Endotoxin adsorbents in extracorporeal blood purification: do they fulfill expectations?, Int J Artif Organs, vol.37, issue.3, p.232, 2014.

H. Aoki, M. Kodama, T. Tani, and K. Hanasawa, Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-inimobilized fiber, Am J Surg, vol.167, issue.4, pp.412-419, 1994.

D. B. Frcpath and F. Cj, Endotoxin removal devices for the treatment of sepsis and septic shock, Lancet Infect Dis, vol.11, issue.1, pp.65-71, 2010.

J. Vincent, P. Laterre, J. Cohen, H. Burchardi, H. Bruining et al.,

. Hemoperfusion and . In, PATIENTS WITH SEVERE SEPSIS SECONDARY TO INTRA-ABDOMINAL INFECTION. Shock, vol.23, issue.5, pp.400-405, 2005.

D. N. Cruz, M. Antonelli, R. Fumagalli, F. Foltran, N. Brienza et al., Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial, Jama, vol.301, issue.23, pp.2445-2452, 2009.

S. D. Barbar, R. Clere-jehl, A. Bourredjem, R. Hernu, F. Montini et al., Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis, New Engl J Med, vol.379, issue.15, pp.1431-1442, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01894630

S. Gaudry, D. Hajage, F. Schortgen, L. Martin-lefevre, B. Pons et al., Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit, New Engl J Medicine, vol.375, issue.2, p.133, 2016.

. Bellomo-r, J. A. Kellum, P. Gandhi-cr, . Mr, and B. Ondulik, The Effect of Intensive Plasma Water Exchange by Hemofiltration on Hemodynamics and Soluble Mediators in Canine Endotoxemia, Am J Resp Crit Care, vol.161, issue.5, pp.1429-1465, 2000.

C. Monard, T. Rimmelé, and C. Ronco, Extracorporeal Blood Purification Therapies for Sepsis, Blood Purificat, vol.47, issue.3, pp.2-15, 2019.

M. C. Gruda, K. Ruggeberg, O. 'sullivan, P. Guliashvili, T. Scheirer et al., Broad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb® sorbent porous polymer beads, Plos One, vol.13, issue.1, p.191676, 2018.

T. Rimmelé, A. Assadi, M. Cattenoz, O. Desebbe, C. Lambert et al., Highvolume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs, Nephrol Dial Transpl, vol.24, issue.2, pp.421-427, 2009.

K. Staubach, M. Boehme, M. Zimmermann, and V. Otto, A new endotoxin adsorption device in Gram-negative sepsis: use of immobilized albumin with the MATISSE® adsorber, Transfus Apher Sci, vol.29, issue.1, pp.93-101, 2003.

K. Reinhart, A. Meier-hellmann, R. Beale, H. Forst, D. Boehm et al., Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gramnegative sepsis&ast

, Crit Care Med, vol.32, issue.8, pp.1662-1670, 2004.

K. Tsuchida, Y. Takemoto, K. Sugimura, R. Yoshimura, K. Yamamoto et al.,

, Adsorption of Endotoxin by Beta2-Microglobulin Adsorbent Column (Lixelle): The New Approach for Endotoxinemia, vol.6, pp.116-124, 2002.

T. Taniguchi, F. Hirai, Y. Takemoto, K. Tsuda, K. Yamamoto et al., A novel adsorbent of circulating bacterial toxins and cytokines: The effect of direct hemoperfusion with CTR column for the treatment of experimental endotoxemia&ast

, Crit Care Med, vol.34, issue.3, pp.800-806, 2006.

K. Kono, S. Toda, K. Hora, and K. Kiyosawa, Direct Hemoperfusion With a ?2

, Microglobulin-selective Adsorbent Column Eliminates Inflammatory Cytokines and Improves Pulmonary Oxygenation, Ther Apher Dial, vol.13, issue.1, pp.27-33, 2009.

H. Shum, K. Chan, and W. Yan, Alteco endotoxin hemoadsorption in Gram-negative septic shock patients, Crit Care, vol.17, issue.2, p.68, 2013.

P. Toft, R. Schmidt, A. C. Broechner, B. U. Nielsen, P. Bollen et al., Effect of Plasmapheresis on the Immune System in Endotoxin-Induced Sepsis, Blood Purificat, vol.26, issue.2, pp.145-50, 2008.

J. H. Reeves, A Review of Plasma Exchange in Sepsis, Blood Purificat

R. Bambauer, C. Bambauer, B. Lehmann, R. Latza, R. Schiel et al., Technical and Clinical Aspects. Sci World J, p.314283, 2012.

G. R. Thompson and H. Group, Recommendations for the use of LDL apheresis

, Atherosclerosis, vol.198, issue.2, pp.247-55, 2008.

E. Bruckert, O. Kalmykova, R. Bittar, V. Carreau, S. Béliard et al., Longterm outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France, Atherosclerosis, vol.257, pp.130-137, 2017.

R. Tatamia, N. Inoue, H. Itoh, B. Kishino, N. Koga et al., Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study

J. De-gennes, R. Touraine, B. Maunand, J. Truffert, and P. Laudat,

, Bulletins Et Mémoires De La Société Médicale Des Hôpitaux De Paris, vol.118, pp.1377-402, 1967.

T. Agishi, I. Kaneko, Y. Hasuo, Y. Hayasaka, T. Sanaka et al., Double filtration plasmapheresis, Transactions -Am Soc Artif Intern Organs, vol.26, pp.406-417, 1980.

W. Stoffel and T. Demant, Selective removal of apolipoprotein B-containing serum lipoproteins from blood plasma, Proc National Acad Sci, vol.78, issue.1, pp.611-616, 1981.

H. Mabuchi, I. Michishita, M. Takeda, H. Fujita, J. Koizumi et al., A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit

, Atherosclerosis, vol.68, issue.1-2, pp.19-25, 1987.

J. Drager, . Kraenzle, . Schaper, . Toepfer, and . Zygan, DALI-the first human whole-blood low-density lipoprotein and lipoprotein (a) apheresis system in clinical use: procedure and clinical results, Eur J Clin Invest, vol.28, issue.12, pp.994-1002, 1998.

C. Keller, P. Grützmacher, F. Bahr, A. Schwarzbeck, A. A. Kroon et al., LDLapheresis with dextran sulphate and anaphylactoid reactions to ACE inhibitors, Lancet, vol.341, issue.8836, pp.60-61, 1993.

P. Matzinger, The Danger Model: A Renewed Sense of Self, Science, vol.296, issue.5566, pp.301-306, 2002.

P. Matzinger, Tolerance, danger, and the extended family, Annu Rev Immunol, vol.12, issue.1, pp.991-1045, 1994.

L. T. Van-eijk, P. Pickkers, P. Smits, W. Van-den-broek, M. P. Bouw et al., Microvascular permeability during experimental human endotoxemia: an open intervention study, Crit Care, vol.9, issue.2, pp.157-64, 2005.

C. Sauter and C. Wolfensberger, INTERFERON IN HUMAN SERUM AFTER INJECTION OF ENDOTOXIN. Lancet, vol.316, issue.8199, pp.852-855, 1980.

R. Sender, S. Fuchs, and R. Milo, Revised Estimates for the Number of Human and Bacteria Cells in the Body, Plos Biol, vol.14, issue.8, p.1002533, 2016.

C. Vors, G. Pineau, J. Drai, E. Meugnier, S. Pesenti et al., Postprandial Endotoxemia Linked With Chylomicrons and Lipopolysaccharides Handling in Obese Versus Lean Men: A Lipid Dose-Effect Trial, J Clin Endocrinol Metabolism, vol.100, issue.9, pp.3427-3462, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01981637

M. Cirstea, K. R. Walley, J. A. Russell, L. R. Brunham, K. R. Genga et al., Decreased high-density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsis, Intensive Care Med, vol.38, pp.289-94, 2007.

L. Lagrost, C. Girard, S. Grosjean, D. Masson, V. Deckert et al., Low Preoperative Cholesterol Level Is a Risk Factor of Sepsis and Poor Clinical Outcome in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass&ast, Crit Care Med, vol.42, issue.5, pp.1065-73, 2014.

L. Lagrost, C. Girard, D. Masson, and C. Bonithon-kopp, The authors reply, Crit Care Med, vol.42, issue.10, pp.686-693, 2014.

T. Ekbom, L. Lindholm, J. Lanke, and P. Nilsson-ehle, Decrease in high density lipoprotein cholesterol during prolonged storage, Scand J Clin Laboratory Investigation, vol.56, issue.2, pp.97-101, 2009.

L. Ma, E. Waldmann, E. M. Ooi, D. C. Chan, H. P. Barrett et al., Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease, Eur J Clin Invest, vol.49, issue.2, p.13053, 2019.

J. H. Levels, P. R. Abraham, E. P. Van-barreveld, J. C. Meijers, and S. J. Van-deventer,

, Distribution and Kinetics of Lipoprotein-Bound Lipoteichoic Acid, Infect Immun, vol.71, issue.6, pp.3280-3284, 2003.

J. Scheiman, J. M. Luber, T. A. Chavkin, T. Macdonald, A. Tung et al.,

, Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism, Nat Med, vol.25, issue.7, pp.1104-1113, 2019.

, ANNEXE 1